Robert McWhirter, president and portfolio manager, Selective Asset Management Inc.

ProMetic Life Sciences Inc. (PLI-TSX): The biopharmaceutical company has developed technologies to remove contaminants from blood and recover valuable proteins from plasma. It has negotiated $21-million in investment agreements with China’s Shenzhen Hepalink Pharmaceutical Co. Ltd. ProMetic, which will use part of those funds to develop therapeutics for blood-related disorders, he said.

it has started dudes...crediblity = visibility